Literature DB >> 27561982

Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.

Stacey C Sigmon1, George E Bigelow2.   

Abstract

Entities:  

Keywords:  Buprenorphine; implant; medication-assisted treatment; opioid; opioid use disorder; sustained-release

Mesh：

Substances：

Year:  2016        PMID： 27561982     DOI： 10.1111/add.13539

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  6 in total

1.  Innovations in efforts to expand treatment for opioid use disorder.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2019-08-21       Impact factor: 4.018

Review 2.  Medications for substance use disorders (SUD): emerging approaches.

Authors:  Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Expert Opin Emerg Drugs       Date:  2017-10-30       Impact factor: 4.191

3.  Perception of a New Prolonged-Release Buprenorphine Formulation in Patients with Opioid Use Disorder: The PREDEPO Study.

Authors:  Francisco Salvador Pascual; Alvaro Muñoz; Rodrigo Oraa; Gerardo Flórez; Pilar Notario; Pedro Seijo; Begoña Gonzalvo; Carla Assaf; Manuel Gómez; Miguel Ángel Casado
Journal:  Eur Addict Res       Date:  2021-11-01       Impact factor: 4.000

4.  Improving recruitment to pharmacological trials for illicit opioid use: findings from a qualitative focus group study.

Authors:  Joanne Neale; Charlotte N E Tompkins; Rebecca McDonald; John Strang
Journal:  Addiction       Date:  2018-02-21       Impact factor: 6.526

5.  Prolonged-release opioid agonist therapy: qualitative study exploring patients' views of 1-week, 1-month, and 6-month buprenorphine formulations.

Authors:  Joanne Neale; Charlotte N E Tompkins; John Strang
Journal:  Harm Reduct J       Date:  2019-04-03

6.  Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences.

Authors:  Joanne Neale; Charlotte N E Tompkins; John Strang
Journal:  Drug Alcohol Rev       Date:  2019-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.